Cytek Biosciences, Inc. (CTKB) vs SiBone (SIBN)
Cytek Biosciences, Inc. and SiBone are both Medical Devices companies. SiBone is the larger, with a market value of $830.0M against $744.8M — 1.1× the size. SiBone grew revenue faster over the last twelve months: 15.3% against 5.44%. SiBone has the higher net margin (−6.85% vs −39.0%) and the higher return on invested capital (−15.4% vs −46.4%). Across the 18 metrics below, SiBone leads on 14 and Cytek Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | CTKB | SIBN | Medical Devices median |
|---|---|---|---|
| Gross margin | 53.23% | 79.53% | 56.01% |
| Operating margin | (21.60%) | (8.31%) | (15.03%) |
| Net margin | (38.98%) | (6.85%) | (20.40%) |
| Free cash flow margin | (5.79%) | (2.05%) | (7.24%) |
| Return on equity | (23.04%) | (8.30%) | (15.32%) |
| Return on assets | (17.14%) | (6.10%) | (19.72%) |
| Return on invested capital | (46.36%) | (15.40%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack